The FDA announced on 2026-09-15 that Insight Pharmaceuticals LLC is voluntarily recalling Clear Eyes Redness Relief eye drops due to a lack of sterility assurance. The recall affects specific lots distributed nationwide.
How to tell if you have it
- Brand: Insight Pharmaceuticals
- Product: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%)
- NDC: 67172-797-15
- Lot #: RL25G04, Exp. Date 07/2027
- Lot #: RL2H02, Exp. Date 08/2027
- Size: 0.5 fl oz (15mL)
- Distribution: Nationwide in the USA
The hazard
The recall is due to a lack of assurance of sterility in the eye drops, according to the FDA.
Context
GovInfoNow's records show Insight Pharmaceuticals LLC has 2 other recalls on record since 2023-12-21. Other recent recalls of similar products include Clear Eyes Eye Drops Recalled for Sterility Risk (2026-07-29), K.C. Pharmaceuticals Ultra Lubricating Eye Drops Recall: Lack of Sterility Risk (2026-03-03) and K.C. Pharmaceuticals Dry Eye Relief Eye Drops Recall: Lack of Sterility Assurance (2026-03-03).